Evidence map›Paper›PMID 15924506›Full record

ArticleDrug safety2005

Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database.

Roberto Leone, Anita Conforti, Mauro Venegoni, Domenico Motola, Ugo Moretti, Ilaria Meneghelli, Alfredo Cocci, Giulia Sangiorgi Cellini, Stefania Scotto, Nicola Montanaro and 1 more

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Drug safety, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 59 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Drug-Induced Anaphylaxis Documented in Electronic Health Records.The journal of allergy and clinical immunology. In practice · 2019
    Article
  8. Article
  9. Drug-induced anaphylactic reactions in Indian population: A systematic review.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2014
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Peanuts can contribute to anaphylactic shock by activating complement.The Journal of allergy and clinical immunology · 2009
    Article
  15. Article
  16. Article
  17. Article
  18. Use and safety profile of antiepileptic drugs in Italy.European journal of clinical pharmacology · 2007
    Article
  19. Hepatic adverse drug reactions: a case/non-case study in Italy.European journal of clinical pharmacology · 2007
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Roberto LeoneClinical Pharmacology Unit, Reference Centre for Education and Communication within the WHO Programme for International Drug Monitoring, University of Verona, Verona, Italy. rleone@sfm.univr.it
Anita Conforti
Mauro Venegoni
Domenico Motola
Ugo Moretti
Ilaria Meneghelli
Alfredo Cocci
Giulia Sangiorgi Cellini
Stefania Scotto
Nicola Montanaro
Giampaolo Velo
University of Verona · ITUniversity of Bologna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo identify the number of cases of anaphylaxis reported in association with different classes of drugs and compare it with other reports contained in the same database.

methodsThe data were obtained from a database containing all of the spontaneous reports of adverse drug reactions (ADRs) coming from the Italian regions of Emilia Romagna, Lombardy and the Veneto, which are the main contributors to the Italian spontaneous surveillance system. The ADRs reported between January 1990 and December 2003 with a causality assessment of certainly, probably or possibly drug related (according to the WHO criteria) were analysed using a case/non-case design. The cases were defined as the reactions already coded by the WHO preferred terms of 'anaphylactic shock' or 'anaphylactoid reaction' (this last term also included anaphylactic reaction) and those with a time of event onset that suggested an allergic reaction and involved at least two of the skin, respiratory, gastrointestinal, CNS or cardiovascular systems; the non-cases were all of the other ADR reports. The frequency of the association between anaphylaxis and the suspected drug in comparison with the frequency of anaphylaxis associated to all of the other drugs was calculated using the ADR reporting odds ratio (ROR) as a measure of disproportionality.

resultsOur database contained 744 cases (including 307 cases of anaphylactic shock with 10 deaths) and 27 512 non-cases. The percentage of anaphylaxis cases reported in inpatients was higher than that among outpatients (59.1% vs 40.9%). This distribution is significantly different from that of the other ADR reports that mainly refer to outpatients. After intravenous drug administrations, anaphylactic shock cases were more frequent than anaphylactoid reactions or other ADRs, but more than one-third of these reactions were caused by an oral drug. Blood substitutes and radiology contrast agents had the highest RORs. Among the systemic antibacterial agents, anaphylaxis was disproportionally reported more often for penicillins, quinolones, cephalosporins and glycopeptides, but diclofenac was the only NSAID with a significant ROR. As a category, vaccines had a significantly lower ROR, thus indicating that anaphylaxis is reported proportionally less than other ADRs.

conclusionsAnaphylaxis is a severe ADR that may also occur with commonly used drugs. It represents 2.7% of all of the ADRs reported in an Italian spontaneous reporting database.

Indexed as

Adverse Drug Reaction Reporting SystemsAnaphylaxisAnti-Bacterial AgentsAntipyrineCase-Control StudiesContrast MediaDatabases, FactualDiclofenacDipyroneFemaleHumansInpatientsItalyMaleMiddle AgedOutpatientsAnti-Bacterial AgentsAntipyrineContrast MediaDiclofenacDipyronePolygelinepropyphenazone

Identifiers

PMID15924506
OpenAlexW2167177035

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.